Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 1 (HMGN1P1)

Target
HMGN1P1
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

HMGN1P1 (High mobility group nucleosome binding domain 1 pseudogene 1) is a processed pseudogene related to the high mobility group protein family, specifically the nucleosome binding domain 1 gene. Pseudogenes are genetic sequences that closely resemble functional genes but typically lack protein-coding capability due to accumulated mutations. Recent evidence from other pseudogene families (not directly HMGN1P1) suggests pseudogenes may impact gene expression regulation, acting as RNA decoys or affecting mRNA stability by competing with their parent genes for regulatory factors or miRNAs. In some cases, such as the HMGA1 pseudogenes, abnormal expression and chromosomal rearrangement have been reported in tumors, potentially influencing malignant progression and epigenetic regulation[1][2]. However, no convincing evidence defines HMGN1P1 as a functional regulatory RNA or protein, nor as a direct disease-modifying or therapeutic target.

02

Mechanism of action

None *No known drug mechanism is directed toward HMGN1P1 or comparable pseudogenes, except in rare RNAi studies targeting regulatory pseudogenes[1].*

03

Biological functions

Possible regulation of parental gene expression via RNA-mediated mechanisms, such as acting as a miRNA decoy or interfering with mRNA stability (shown for similar pseudogenes, e.g., HMGA1Ps, PTENP1, but not directly established for HMGN1P1)Other
04

Disease associations

Other (No direct evidence for disease association; the closest analogies are for HMGA1 pseudogene family roles in cancer and diabetes, but these do not apply directly to HMGN1P1[1][2].)
05

Safety considerations

None *As a non-coding pseudogene, HMGN1P1 is not associated with classical drug-related safety concerns; more general issues concern potential off-target effects for therapeutic nucleic acid drugs if targeting pseudogenes.*

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 1 (HMGN1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 1 (HMGN1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call